Mutual antagonism of rheumatoid arthritis and hay fever; a role for type 1/type 2 T cell balance

Annals of the Rheumatic Diseases

Volumn 57, Issue 5, 1998, Pages 275-280

  Verhoef, Catharina M ^a   Van Roon, Joel A G ^a   Vianen, Marieke E ^a   Bruijnzeel Koomen, Carla A F M ^a   Lafeber, Floris P J G ^a   Bijlsma, Johannes W J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ATOPY; DISEASE ASSOCIATION; FEMALE; HAY FEVER; HUMAN; HUMORAL IMMUNITY; IMMUNOREGULATION; INTERFERON PRODUCTION; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; T LYMPHOCYTE ACTIVATION;

EID: 0031824235     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.57.5.275     Document Type: Article

References (31)

1. Panayi GS, Lanchbury JS, Kingsley GH. The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum 1992;35:729-35.
2. Jendro MC, Ganten T, Mattesen EL, Weyand CM, Goronzy JJ. Emergence of oligoclonal T cell populations following therapeutic T cell depletion in rheumatoid arthritis. Arthritis Rheum 1995;38:1242-51.
3. Romagnani S. Biology of human Th1 and Th2 cells. J Clin Immunol 1995;5:121-9.
4. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996;17: 138-46.
5. Schulze-Koops H, Lipsky PE, Kavanaugh AF, Davis LS. Elevated Th1- or Th0-like cytokin mRNA in peripheral circulation of patients with rheumatoid arthritis. J Immunol 1995;155:5029-37.
6. Dolhain RJEM, Van Der Heiden AN, Ter Haar NT, Breedveld FC, Miltenburg AMM. Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis. Arthritis Rheum 1996; 39:1961-9.
7. Elliot MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen JS, et al. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor a (cA2) versus placebo in rheumatoid arthritis. Lancet 1994; 344:1105-10.
8. Lebsack ME, Paul CC, Martindale JJ, Catalano MA. A dose- and regimen-ranging study of IL-1 receptor antagonist in patients with rheumatoid arthritis. Arthritis Rheum 1993;39:S39.
9. Del Prete G. Human Th1 and Th2 lymphocytes: their role in the pathophysiology of atopy. Allergy 1992;47:450-5.
10. Romagnani S. Regulation of the development of type 2 T-helper cells in allergy. Curr Opin Immunol 1994;6:838-46.
11. Mudde GC, Bheekha R, Bruijnzeel-Koomen CAFM. IgE-mediated antigen presentation. Allergy 1992;50:193-9.
12. Pene J, Rivier A, Lagier B, Beckcr WM, Michel FB, Bousquet J. Differences in Il-4 release by PBMC are related with heterogeneity of atopy. Immunology 1994;81:58-64.
13. Ricci M. Il-4: a key cytokine in atopy. Clin Exp Allergy 1094;24:801-12.
14. Van Roon J, Van Roy JLAM, Gmelig-Meyling FHJ, Lafeber FPJG, Bijlsma JWJ. Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4. Arthritis Rheum 1996;39:829-35.
15. Miossec P, Briolay J, Dechanet J, Wijdenes J, Martinez-Valdes H, Banchereau J. Inhibition of the production of proinflammatory cytokines and immunoglobulines by interleukin-4 in an ex vivo model of rheumatoid arthritis. Arthritis Rheum 1992;35:874-83.
16. Joosten LAB, Lubberts E, Durez P, Helsen MMA, Jacobs MJM, Goldman M, et al. The role of IL-4 and IL-10 in the regulation of murine collagen induced arthritis. Arthritis Rheum 1997;40:249-60.
17. Mauri C, Williams RO, Walmsley M, Feldmann M. Relationship between Th1/Th2 cytokine patterns and the arthritogemc response in CIA. Eur J Immunol 1996;26: 1511-8.
18. American Rheumatism Association. Dictionary of the rheumatic diseases. Vol 1. Division ARA functional classes. New York: Contact Associates International, 1988.
19. Ewan PW, Coote D. Evaluation of a capsulated hydrophilic carrier polymer (the ImmunoCAP) for measurement of specific IgE antibodies. Allergy 1990;45:22-9.
20. Merrett TG, Pantin CFA, Dimond AH, Merrett J. Screening for IgE-mediated allergy. Allergy 1980;35:491-501.
21. Malling HJ. Methods of skin testing. Allergy 1994;49 (suppl):55-6.
22. Pastorello EA. Skin tests for diagnosis of IgE-mediated allergy. Allergy 1994;49 (suppl):57-62.
23. Thompson PW, Silman A, Kirwan JR, Currey HLF. Articular indices of joint inflammation in rheumatoid arthritis. Arthritis Rheum 1987;30:618-23.
24. Van Der Heide DM, Van Riel PL, Nuver-Zwart IH, Gribnau FW, Van De Putte LB. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet 1989;i:1036-8.
25. Van der Pouw-Kraan T, Van Kooten C, Rensink I, Aarden L. Interleukin-4 production by human T cells. Eur J Immunol 1992;22:1237-41.
26. June CH, Bluestone JA, Nadler LM, Thompson CB. The B7 and CD28 receptor families. Immunol Today 1994;15: 321-31.
27. Marsh DG, Meyers DA, Bias WB. The epidemiology and genetics of atopic allergy. N Engl J Med 1981;305:1551-8.
28. Wüthrich B, Schindler C, Leuenberger P, Ackermann-Liebrich U, SAPALDIA- Team. Prevalence of atopy and pollinosis in the adult population of Switzerland (SAPALDIA Study). Int Arch Allergy Immunol 1995;106:149-56.
29. O'Driscoll BRC, Milburn HJ, Kemeny DM, Cochrane GM, Panayi GS. Atopy and rheumatoid arthritis. Clin Allergy 1985;15:547-53.
30. Oro AS, Guarino TJ, Driver R, Steinman L, Umetsu DT. Regulation of disease susceptibility: decreased prevalence of IgE-mediated allergic disease in patients with multiple sclerosis. J Allergy Clin Immunol 1996;97:1402-8.
31. Shirakawa T, Enomoto T, Shimazu S, Hopkin JM. The inverse association between tuberculin responses and atopic disorder. Science 1997;275:77-9.